The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!

Current Opinion in Microbiology

Volumn 8, Issue 5, 2005, Pages 518-524

  Thomson, Jodi M ^a   Bonomo, Robert A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEMBRANE PROTEIN; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UREIDOPENICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL INFECTION; BIOFILM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE PERSONNEL; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; GRAM-NEGATIVE BACTERIA; HUMANS; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 25144472273     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2005.08.014     Document Type: Review

References (52)

1. N. Zetola, J.S. Francis, E.L. Nuermberger, and W.R. Bishai Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat Lancet Infect Dis 5 2005 275 286
2. I. Chopra Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures Expert Rev Anti Infect Ther 1 2003 45 55
3. R.E. Hancock Mechanisms of action of newer antibiotics for Gram-positive pathogens Lancet Infect Dis 5 2005 209 218
4. M.H. Kollef Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems Respir Care 49 2004 1530 1541
5. D. Banerjee, and D. Stableforth The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs 60 2000 1053 1064
6. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317
7. D.M. Livermore Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34 2002 634 640
8. C. Llanes, D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously Antimicrob Agents Chemother 48 2004 1797 1802
9. X.Z. Li, L. Zhang, and K. Poole Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa J Antimicrob Chemother 45 2000 433 436
10. S. Murakami, R. Nakashima, E. Yamashita, and A. Yamaguchi Crystal structure of bacterial multidrug efflux transporter AcrB Nature 419 2002 587 593
11. O. Lomovskaya, and M. Totrov Vacuuming the periplasm J Bacteriol 187 2005 1879 1883
12. K. Poole Efflux-mediated multiresistance in Gram-negative bacteria Clin Microbiol Infect 10 2004 12 26
13. R.E. Hancock, and F.S. Brinkman Function of pseudomonas porins in uptake and efflux Annu Rev Microbiol 56 2002 17 38
14. D.J. Wolter, N.D. Hanson, and P.D. Lister Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance FEMS Microbiol Lett 236 2004 137 143
15. D.M. Livermore β-Lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557 584
16. M. Watanabe, S. Iyobe, M. Inoue, and S. Mitsuhashi Transferable imipenem resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 35 1991 147 151
17. T.R. Walsh, M.A. Toleman, L. Poirel, and P. Nordmann Metallo-β- lactamases: the quiet before the storm? Clin Microbiol Rev 18 2005 306 325 A comprehensive state-of-the-art review by leading investigators in the field. This review describes the epidemiology, genetics and microbiology of these emerging metallo-β-lactamases, highlighting IMP, VIM, SPM and GES. It is well-referenced (greater than 300 citations) and serves as a sentinel article for newcomers and experts in the field.
18. L. Lauretti, M.L. Riccio, A. Mazzariol, G. Cornaglia, G. Amicosante, R. Fontana, and G.M. Rossolini Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate Antimicrob Agents Chemother 43 1999 1584 1590
19. G. Cornaglia, A. Mazzariol, L. Lauretti, G.M. Rossolini, and R. Fontana Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase Clin Infect Dis 31 2000 1119 1125
20. A. Tsakris, S. Pournaras, N. Woodford, M.F. Palepou, G.S. Babini, J. Douboyas, and D.M. Livermore Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece J Clin Microbiol 38 2000 1290 1292
21. K. Lee, W.G. Lee, Y. Uh, G.Y. Ha, J. Cho, and Y. Chong VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals Emerg Infect Dis 9 2003 868 871
22. M.A. Toleman, K. Rolston, R.N. Jones, and T.R. Walsh blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States Antimicrob Agents Chemother 48 2004 329 332
23. N. Lincopan, J.A. McCulloch, C. Reinert, V.C. Cassettari, A.C. Gales, and E.M. Mamizuka First isolation of metallo-β-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil J Clin Microbiol 43 2005 516 519
24. H. Nishio, M. Komatsu, N. Shibata, K. Shimakawa, N. Sueyoshi, T. Ura, K. Satoh, M. Toyokawa, T. Nakamura, and Y. Wada Metallo-β-lactamase-producing Gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan J Clin Microbiol 42 2004 5256 5263
25. E. Drenkard Antimicrobial resistance of Pseudomonas aeruginosa biofilms Microbes Infect 5 2003 1213 1219
26. D. Landman, J.M. Quale, D. Mayorga, A. Adedeji, K. Vangala, J. Ravishankar, C. Flores, and S. Brooks Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned Arch Intern Med 162 2002 1515 1520
27. P.T. Scott, K. Petersen, J. Fishbain, D.W. Craft, A.J. Ewell, K. Moran, D.C. Hack, G.A. Deve, S. Riddell, and G. Christopher Acinetobacter baumannii infections among patients MMWR Morb Mortal Wkly Rep 53 2004 1063 1066
28. G. Bou, A. Oliver, and J. Martinez-Beltran OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain Antimicrob Agents Chemother 44 2000 1556 1561
29. M.A. Mussi, A.S. Limansky, and A.M. Viale Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins Antimicrob Agents Chemother 49 2005 1432 1440 This was the first study to show that an IS element is responsible for carbapenem resistance in A. baumannii.
30. J. Quale, S. Bratu, D. Landman, and R. Heddurshetti Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City Clin Infect Dis 37 2003 214 220
31. S.L. Chau, Y.W. Chu, and E.T. Houang Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3 Antimicrob Agents Chemother 48 2004 4054 4055
32. I. Marchand, L. Damier-Piolle, P. Courvalin, and T. Lambert Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system Antimicrob Agents Chemother 48 2004 3298 3304 This study and [33] describe the importance of the efflux pump and its regulation in A. baumannii.
33. S. Magnet, P. Courvalin, and T. Lambert Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 Antimicrob Agents Chemother 45 2001 3375 3380
34. P. Nordmann, and L. Poirel Emerging carbapenemases in Gram-negative aerobes Clin Microbiol Infect 8 2002 321 331
35. K.M. Hujer, N.S. Hamza, A.M. Hujer, F. Perez, M.S. Helfand, C.R. Bethel, J.M. Thomson, V.E. Anderson, M. Barlow, and L.B. Rice Identification of a new variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: characterizing a new family of ClassC enzymes. Antimicrob Agents Chemother 49 2005 2941 2948
36. F. Paganin, F. Lilienthal, A. Bourdin, N. Lugagne, F. Tixier, R. Genin, and J.L. Yvin Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor Eur Respir J 24 2004 779 785
37. K. Bush New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy Clin Infect Dis 32 2001 1085 1089
38. D.L. Paterson, K.M. Hujer, A.M. Hujer, B. Yeiser, M.D. Bonomo, L.B. Rice, and R.A. Bonomo Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases Antimicrob Agents Chemother 47 2003 3554 3560
39. P.E. Coudron, N.D. Hanson, and M.W. Climo Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases J Clin Microbiol 41 2003 772 777
40. J.J. Yan, W.C. Ko, H.M. Wu, S.H. Tsai, C.L. Chuang, and J.J. Wu Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan J Clin Microbiol 42 2004 5337 5340
41. D.L. Paterson, W.C. Ko, A. Von Gottberg, S. Mohapatra, J.M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K.P. Klugman, and R.A. Bonomo International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections Ann Intern Med 140 2004 26 32
42. E.P. Hyle, A.D. Lipworth, T.E. Zaoutis, I. Nachamkin, N.O. Fishman, W.B. Bilker, X. Mao, and E. Lautenbach Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species Clin Infect Dis 40 2005 1317 1324
43. G.A. Jacoby, D.M. Mills, and N. Chow Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae Antimicrob Agents Chemother 48 2004 3203 3206
44. H. Yigit, A.M. Queenan, G.J. Anderson, A. Domenech-Sanchez, J.W. Biddle, C.D. Steward, S. Alberti, K. Bush, and F.C. Tenover Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 45 2001 1151 1161
45. H. Yigit, A.M. Queenan, J.K. Rasheed, J.W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush, and F.C. Tenover Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2 Antimicrob Agents Chemother 47 2003 3881 3889
46. ••].
47. ••] make up a collection of articles that describe the emergence of a serine carbapenemase in K. pneumoniae. The authors feel that this will be one of the biggest threats to β-lactam therapy.
48. R.N. Jones, H.K. Huynh, D.J. Biedenbach, T.R. Fritsche, and H.S. Sader Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations J Antimicrob Chemother 54 2004 144 154
49. S. Mushtaq, Y. Ge, and D.M. Livermore Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential Antimicrob Agents Chemother 48 2004 3086 3092
50. R.N. Jones, H.K. Huynh, and D.J. Biedenbach Activities of doripenem (S-4661) against drug-resistant clinical pathogens Antimicrob Agents Chemother 48 2004 3136 3140
51. J. Li, R.L. Nation, R.W. Milne, J.D. Turnidge, and K. Coulthard Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria Int J Antimicrob Agents 25 2005 11 25
52. K. Lolans, A.M. Queenan, K. Bush, A. Sahud, and J.P. Quinn First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States Antimicrob Agents Chemother 49 2005 3538 3540